GTC A.I CyberSecurity Scoring
03/04/2026
Access Monitoring Plan
Access Monitoring Plan
No incidents recorded for Genomic Testing Cooperative in 2026.
No incidents recorded for Genomic Testing Cooperative in 2026.
No incidents recorded for Genomic Testing Cooperative in 2026.
Biotechnology Research
Syneos Health® is a leading fully integrated biopharmaceutical solutions organization built to accelerate customer success. We translate unique clinical, medical affairs and commercial insights into outcomes to address modern market realities. We bring together a talented team of professionals with a deep understanding of patient and physician behaviors and market dynamics. Together we share insights, use the latest technologies and apply advanced business practices to speed our customers’ delivery of important therapies to patients. Syneos Health supports a diverse, equitable and inclusive culture that cares for colleagues, customers, patients, communities and the environment.
About Genentech We're passionate about finding solutions for people facing the world's most difficult-to-treat conditions. That is why we use cutting-edge science to create and deliver innovative medicines around the globe. To us, science is personal. Making a difference in the lives of millions starts when you make a change in yours. If you’d like to join our team, view our openings at gene.com/careers. Our patient resource center is dedicated to getting patients and caregivers to the right resources. You can reach them at 1 (877) GENENTECH (436-3683) Monday-Friday, 6am-5pm PST or [email protected]. Community Guidelines: 1. We want to foster positive conversation around the issues we are passionate about. To that end, we remove profanity, content that contains threatening language, content that is aimed at private individuals, personal information, and repeated unwanted messages. 2. Don’t mention any medicines by name — ours or anyone else’s. Because of the fair balance rules governing our industry, we cannot post any comments that reference any pharmaceutical brand, product, or service. Please do not mention any specific medicines by name, or include any links to third party sites in your comments. 3. This isn’t the place to report or discuss side effects. This site is not intended as a forum for reporting side effects experienced while taking a Genentech product. Instead, you should report any side effects to Genentech Drug Safety at 1-888-835-2555. You can also report side effects of any prescription product directly to the FDA at 1-800-FDA-1088 or by visiting www.FDA.gov/medwatch. 4. Don’t pitch your product or service. Please don't use our page as a place to promote your product or pitch your services. Please also avoid posting links to external sites. We reserve the right to remove any posts that are deemed promotional.
NIH is the only agency of its kind. We impact the health of the country and the world through unique and innovative medical research. Did you know that NIH is the largest public funder of biomedical research in the world, investing more than $32 billion a year to enhance life, and reduce illness and disability? NIH funded research has led to breakthroughs and new treatments, helping people live longer, healthier lives, and building the research foundation that drives discovery. Whether you are graduating with a bachelor's degree, working on your doctoral degree, entering the workforce for the first time, or changing careers, NIH offers a place for you to start and plenty of room to grow your career. When you join us, you’re not just advancing your career — you’re driving the health of our country forward. Official LinkedIn Account of the NIH. Privacy policy: http://go.usa.gov/x9svN Comment policy: https://bit.ly/3G6xq94 Engagement ≠ endorsement
A family-owned company, bioMérieux has grown to become a world leader in the field of in vitro diagnostics. Our entrepreneurial adventure, begun over a century ago, is driven by an unrelenting commitment to improve public health worldwide. Since 1963, we've been paving the way in the field of in vitro diagnostics and have contributed greatly to improving public health and making the world a healthier place. The solutions that our teams imagine, develop and manufacture are key to enable healthcare professionals and industry players to make confident decisions to improve patient outcome and ensure consumer safety.
Since our foundation in Dublin, Ireland in 1990, our mission has been to help our clients to accelerate the development of drugs and devices that save lives and improve quality of life. We do this by delivering best in class information, solutions and performance, with an unyielding focus on quality at all times. We offer a full range of consulting, development and commercialisation services from a global network of offices in 53 countries. We focus our innovation on the factors that are critical to our clients – reducing time to market, reducing cost, and increasing quality – and our global team of experts has extensive experience in a broad range of therapeutic areas.
About Thermo Fisher Scientific Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue of approximately $40 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, increasing productivity in their laboratories, improving patient health through diagnostics or the development and manufacture of life-changing therapies, we are here to support them. Our global team delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon and PPD. For more information, please visit www.thermofisher.com.
Avantor® is a leading global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. Our portfolio is used in virtually every stage of the most important research, development and production activities in the industries we serve. Our global footprint enables us to serve more than 300,000 customer locations and gives us extensive access to research laboratories and scientists in more than 180 countries. We set science in motion to create a better world. More than 14,500 strong, our associates are passionate about our mission to set science in motion to create a better world. We share enthusiasm for innovation, excellence, and achievement. Whether we are collaborating with our customers to advance science or solve multifaceted problems, we help them reach their goals more efficiently and effectively. Visit our website to learn more about Avantor.
At Charles River, we are guided by our strong purpose—to create healthier lives—which centers around the patients who rely on the therapeutics we help to develop, the animals in our care, to our planet, and to the passionate and skilled people who are at the heart of our organization and make it all possible. #DrugDiscovery #Biotech #Biotechnology #Pharmaceuticals #CRL
At Gilead, we set – and achieve – bold ambitions to create a healthier world for all people. From our pioneering virology medicines to our growing impact in oncology, we're delivering innovations once thought impossible in medicine. Our focus goes beyond medicines, and we also strive to remedy health inequities and break down barriers to care. We empower our people to tackle these challenges, and we’re all united in our commitment to help millions of people live healthier lives. Social Media Guidelines: https://www.gilead.com/social-media-guidelines
Latest updates, reports, and threat intel affecting the global network.
HOUSTON, March 12, 2026--Genomic Testing Cooperative (GTC), a leading provider of integrated DNA and RNA next-generation sequencing (NGS)...
Published July 14, 2025. By Kathleen Sullivan , Senior Director, Strategy & Operations Ciaran Martin , Professor of Practice Tori Westerhoff , Principal...
Cline is an autonomous coding agent as an SDK, IDE extension, or CLI assistant. Prior to 3.0.30, the Cline Hub dashboard server launched by the cline dashboard command accepts WebSocket connections on the /browser endpoint without validating the Origin header, and when ROOM_SECRET is unset for local 127.0.0.1 binds, isAuthorizedBrowserRequest() allows attacker-controlled websites to send desktopCommand frames that read workspace state, mutate MCP and provider settings, and trigger command execution when a provider or model is configured. This issue is fixed in version 3.0.30.
CoreWCF is a port of the service side of Windows Communication Foundation (WCF) to .NET Core. In version 1.9.0, CoreWCF SPNEGO SecurityContextToken negotiation can expose the proof key recovered from the RSTR when TransportWithMessageCredential with Windows client credentials and session establishment are used, allowing an observer to impersonate the authenticated Windows principal and decrypt or forge WS-SecureConversation traffic. This issue is fixed in version 1.9.1.
CoreWCF is a port of the service side of Windows Communication Foundation (WCF) to .NET Core. Prior to 1.8.1 and 1.9.1, CoreWCF WS-Security endorsing and supporting signature verification does not ensure the selected ds:Signature covers the expected Security header target, allowing an attacker with one captured signed SOAP envelope to replay arbitrary service operations as the victim principal. This issue is fixed in versions 1.8.1 and 1.9.1.
CoreWCF is a port of the service side of Windows Communication Foundation (WCF) to .NET Core. Prior to 1.8.1 and 1.9.1, CoreWCF SAML 1.1 and SAML 2.0 token validation does not correctly resolve the issuer signing key or require signed tokens when IdentityConfiguration is used with federated bindings, allowing an unauthenticated remote attacker to impersonate any principal the trusted STS could issue. This issue is fixed in versions 1.8.1 and 1.9.1.
CoreWCF is a port of the service side of Windows Communication Foundation (WCF) to .NET Core. Prior to 1.8.1 and 1.9.1, CoreWCF SAML token validation does not enforce SubjectConfirmation method URIs or holder-of-key proof keys in SamlSecurityTokenHandler, allowing holder-of-key downgrade or custom confirmation method assertions to authenticate a subject without proving authority over the assertion. This issue is fixed in versions 1.8.1 and 1.9.1.
curl -i -X GET 'https://api.rankiteo.com/underwriter-getcompany-history?
linkedin_id=axa' -H 'apikey: YOUR_API_KEY_HERE'
Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.
Rankiteo is a unified scoring and risk platform that analyzes billions of signals weekly to help organizations gain faster, more actionable insights into emerging threats. Empowering teams to outpace adversaries and reduce exposure.